Nasdaq · CIK 0001094366
RDWR RADWARE LTD
Insider trading from SEC Form 4. Last filing 25 d ago. Close $30.98 on Oct 9, 2026, +43% from the 52-week low and -4% from the high.
In brief
RADWARE LTD (RDWR) has 13 SEC Form 4 filings on file from 8 insiders, the latest filed on Sep 18, 2026. In the last 90 days insiders made 1 open-market buy worth $50k and 2 open-market sells worth $656k, net -$605k.
7 open-market trades have been scored at RDWR. The newest: David Meleh Aviv (Chief Technology Officer) sold $461k of stock on Sep 17, 2026, filed Sep 18, 2026, scored 37 (weak). 2 insiders sold within 14 days of each other around May 29, 2026.
25 Form 144 notices of planned sales are on file, the latest filed Sep 18, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at RADWARE LTD, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | David Meleh Aviv Chief Technology Officer sell | $461k 15,000 shares | -10% | - | |
| 37Weak | Gabriel Malka Chief Operating Officer sell | $195k 6,500 shares | -12% | +36% from low-8% from high | |
| 33Weak | Guy Avidan Chief Financial Officer buy | $50k 2,000 shares | +2% | +20% from low-18% from high | |
| 15Weak | Rivkah Goldriech Chief People Officer sell | $24k 750 shares | -1% | +48% from low0% from high | |
| 45Moderate | Gabriel Malka Chief Operating Officer sell | $210k 7,000 shares | -11% | +40% from low-1% from high | |
| 29Weak | Rivkah Goldriech Chief People Officer sell | $41k 1,375 shares | -2% | +36% from low-4% from high | |
| 37Weak | Gabriel Malka Chief Operating Officer sell | $90k 3,111 shares | -5% | +26% from low-11% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 18, 2026 | David Aviv Officer | 15,000 0.03% of outstanding | $442k | Sep 17, 2026 | none |
| Aug 28, 2026 | Gabi Malka Officer | 6,500 0.02% of outstanding | $185k | Aug 27, 2026 | $210k |
| Jul 10, 2026 | Goldriech Rivkah Officer | 750 0.00% of outstanding | $23k | Jul 9, 2026 | $41k |
| Jun 1, 2026 | Malka Gabriel Officer | 7,000 0.02% of outstanding | $206k | May 29, 2026 | $90k |
| May 11, 2026 | Malka Gabriel Officer | 3,111 0.01% of outstanding | $88k | May 8, 2026 | none |
| Mar 25, 2026 | Gazelle Yoav Officer | 3,111 0.01% of outstanding | $80k | Mar 24, 2026 | $455k |
| Feb 17, 2026 | Gazelle Yoav Officer | 13,750 0.03% of outstanding | $363k | Feb 13, 2026 | $78k |
| Feb 12, 2026 | Gazelle Yoav Officer | 2,750 0.01% of outstanding | $72k | Feb 11, 2026 | none |
| Jan 9, 2026 | Zisapel Roy Officer | 53,678 0.13% of outstanding | $1.3M | Jan 8, 2026 | $2.0M |
| Jan 7, 2026 | Zisapel Roy Officer | 53,678 0.13% of outstanding | $1.3M | Jan 6, 2026 | $657k |
| Jan 5, 2026 | Zisapel Roy Director | 27,647 0.07% of outstanding | $666k | Jan 2, 2026 | none |
| Nov 3, 2025 | Trachtman Cohen Sharon Officer | 3,110 0.01% of outstanding | $80k | Nov 3, 2025 | $138k |
| Aug 18, 2025 | Trachtman Cohen Sharon Officer | 5,583 0.01% of outstanding | $138k | Aug 18, 2025 | $99k |
| Jul 28, 2025 | Zeldis Naama Director | 1,824 0.00% of outstanding | $52k | Jul 28, 2025 | $310k |
| Jul 28, 2025 | Trachtman Cohen Sharon Officer | 2,332 0.01% of outstanding | $66k | Jul 28, 2025 | $44k |
| Jul 9, 2025 | Goldriech Rivkah Officer | 2,500 0.01% of outstanding | $76k | Jul 8, 2025 | $71k |
| Jul 7, 2025 | Goldriech Rivkah Officer | 2,355 0.01% of outstanding | $70k | Jul 3, 2025 | none |
| Jul 7, 2025 | Zeldis Naama Director | 7,224 0.02% of outstanding | $214k | Jul 3, 2025 | $94k |
| Jun 17, 2025 | Gazelle Yoav Officer | 1,274 0.00% of outstanding | $34k | Jun 16, 2025 | $673k |
| Jun 17, 2025 | Zeldis Naama Director | 2,951 0.01% of outstanding | $78k | Jun 16, 2025 | $12k |
| Jun 16, 2025 | Gazelle Yoav Officer | 5,000 0.01% of outstanding | $122k | Jun 13, 2025 | $542k |
| Jun 16, 2025 | Malka Gabriel Officer | 31,196 0.07% of outstanding | $761k | Jun 13, 2025 | $22k |
| Jun 6, 2025 | Gazelle Yoav Officer | 5,000 0.01% of outstanding | $120k | Jun 5, 2025 | $420k |
| Jun 4, 2025 | Gazelle Yoav Officer | 5,301 0.01% of outstanding | $126k | Jun 3, 2025 | $293k |
| Jun 3, 2025 | Gazelle Yoav Officer | 6,278 0.01% of outstanding | $146k | Jun 2, 2025 | $144k |
Transactions
Every row filed, 14 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | David Meleh Aviv Chief Technology Officer | SOpen-market sale Ordinary Shares | -15,000 | $30.71 | $461k | 134,487 | 25 d ago |
| Aug 27, 2026 | Gabriel Malka Chief Operating Officer | SOpen-market sale Ordinary shares | -6,500 | $30.00 | $195k | 47,922 | 43 d ago |
| Jul 28, 2026 | David Meleh Aviv Chief Technology Officer | AGrant or award Ordinary shares | +20,000 | $0.00 | $0 | 149,487 | Aug 14, 2026 |
| Jul 31, 2026 | Guy Avidan Chief Financial Officer | POpen-market purchase Ordinary Shares | +2,000 | $25.21 | $50k | 95,800 | Aug 3, 2026 |
| Jul 9, 2026 | Rivkah Goldriech Chief People Officer | SOpen-market sale Ordinary shares | -750 | $32.00 | $24k | 59,991 | Jul 13, 2026 |
| May 29, 2026 | Gabriel Malka Chief Operating Officer | SOpen-market sale Ordinary shares | -7,000 | $30.00 | $210k | 54,422 | Jun 1, 2026 |
| May 25, 2026 | Israel Mazin director | AGrant or award Stock optionsderivative | +60,000 | $0.00 | $0 | 60,000 | May 27, 2026 |
| May 25, 2026 | Alex Pinchev director | AGrant or award Stock optionsderivative | +60,000 | $0.00 | $0 | 60,000 | May 27, 2026 |
| May 25, 2026 | Stanley Stern director | AGrant or award Stock optionsderivative | +60,000 | $0.00 | $0 | 60,000 | May 27, 2026 |
| May 25, 2026 | Roy Zisapel President & CEO | AGrant or award Ordinary shares | +201,314 | $0.00 | $0 | 2,392,275 | May 27, 2026 |
| May 22, 2026 | Rivkah Goldriech Chief People Officer | SOpen-market sale Ordinary shares | -1,375 | $29.50 | $41k | 60,741 | May 27, 2026 |
| May 25, 2026 | Roy Zisapel President & CEO | AGrant or award Stock optionsderivative | +250,946 | $0.00 | $0 | 250,946 | May 27, 2026 |
| May 8, 2026 | Gabriel Malka Chief Operating Officer | SOpen-market sale Ordinary shares | -3,111 | $29.00 | $90k | 61,422 | May 11, 2026 |
| Apr 1, 2026 | Roy Zisapel President & CEO | WWill or inheritance Ordinary shares | +454,272 | $0.00 | $0 | 2,190,961 | Apr 2, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Guy AvidanChief Financial Officer
- David Meleh AvivChief Technology Officer
- Rivkah GoldriechChief People Officer
- Gabriel MalkaChief Operating Officer
- Israel Mazindirector
- Alex Pinchevdirector
- Stanley Sterndirector
- Roy ZisapelPresident & CEO
Questions about RDWR
Answered from the filings on this page, as of the latest one.
Are insiders buying RDWR?
As of Sep 18, 2026, SEC Form 4 filings show 1 open-market buy worth $50k by 1 insider and 2 open-market sells worth $656k by 2 insiders at RADWARE LTD in the last 90 days, net -$605k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade RDWR on the open market?
David Meleh Aviv (Chief Technology Officer) sold $461k of RDWR on Sep 17, 2026 and filed the Form 4 on Sep 18, 2026. InsiderTell scored 37 (weak).
How many insiders file Form 4 at RADWARE LTD?
8 people have filed a Form 4 at RADWARE LTD, among them Guy Avidan (Chief Financial Officer), David Meleh Aviv (Chief Technology Officer), Rivkah Goldriech (Chief People Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.